Study at a glance
What question did the studies ask?
Researchers asked how vitamin D-related changes in gene activity connect with tissue and whole-body outcomes. Gene activity produces RNA messages used by cells. A changed message does not automatically mean that a tissue works better. Most experiments used cells or animals; one included a year-long trial in older adults.
What did the researchers find?
Some mouse experiments linked receptor or gene-regulatory changes with calcium absorption, blood pressure, glucose handling or tissue scarring. An experiment using deliberately toxic injected vitamin D3 in mice found harmful mineral deposits. Another experiment found a large gene-response change without a clear resting mineral problem. Changes in nerve-insulating myelin structure or muscle fat did not establish better nerve performance or strength. In the human trial, vitamin D3 raised blood vitamin D but did not produce a clear gene response in the measured blood cells.
What does this mean?
The findings depended on the intervention, tissue and conditions. Removing a receptor, changing its partners, giving active hormone and taking vitamin D3 are different interventions. A measured outcome does not prove that one gene or protein contact caused it. Animal findings do not establish a general human treatment benefit or a personal dose.
Read the full article below ↓Vitamin D-related changes in gene activity can accompany changes in calcium balance, metabolism and tissue structure. The strength of the connection depends on what researchers changed and what they measured. Some experiments found recovery, some found harm, and others found no clear change. For the detailed evidence, read Vitamin D, Gene Regulation and Physiological Outcomes: Full Evidence Review.
What question did the studies ask?
Genes contain information used by cells. Transcription makes RNA messages from genes; a changed message does not automatically mean a changed protein or better tissue performance. Vitamin D and Gene Expression explains gene activity. The vitamin D receptor is a protein that can help regulate it, as described in Vitamin D Receptors.
Researchers studied receptor restoration, altered regulatory DNA, changed receptor partners and different treatments. Vitamin D and Transcription Factors introduces those cooperating proteins, while Vitamin D and Nuclear Receptors places the receptor in its wider family. Most studies used cells or animals. Active vitamin D hormone, laboratory-made receptor activators and oral vitamin D3 are different exposures.
Calcium balance and receptor changes
Restoring a receptor mainly in the intestine of otherwise receptor-deficient mice recovered measured calcium absorption, growth and blood calcium and parathyroid hormone. This hormone helps regulate calcium balance. Some gene responses differed from the comparison animals, and hair loss remained. The main comparators retained one working receptor-gene copy; some restored receptor signal also appeared in kidney. The experiment tested what restoration could accomplish, rather than what deleting the receptor only in intestine would prevent. It did not isolate gene transcription as the only mechanism. [1]
A second study changed DNA regions controlling a vitamin D breakdown gene. The induced gene response fell substantially, but young mice showed no clear resting difference in blood calcium, phosphate, two measured regulatory hormones or weight. Some vitamin D metabolites changed. The DNA changes also affected a neighbouring regulatory site. Compensation and the tested age and conditions limit any claim that the animals were physiologically identical. [2]
In another mouse study, a receptor missing an activation region could not recruit the tested activating proteins normally, yet retained other interactions. Those mice had more severe mineral and bone problems than mice with no receptor. A mineral-rich diet helped the receptor-null mice more than the altered-receptor mice. Changes restricted to selected bone-related cell groups did not reproduce the full problem, although the groups were broad and one deletion was incomplete. This points beyond bone cells alone; it does not prove that one suppressed transport gene caused the systemic problem or that all remaining actions were independent of hormone binding. [3]
Blood pressure and metabolism
Mice lacking the receptor had increased renin and angiotensin II, components of a blood-pressure control system, with raised pressure. An inhibitor reduced the pressure difference. Active vitamin D also lowered renin gene activity in engineered kidney-derived cells. Calcium controls strengthened the connection, but other hormone changes and whole-body receptor loss remained alternative contributors. The study did not identify a particular suppressive DNA element or prove the entire mechanism inside the animal. It does not show that supplements treat human hypertension. [4]
Mixed liver cells from unborn mouse offspring of vitamin D-deficient mothers transferred altered insulin responses to other mice kept vitamin-D-sufficient. The mixture included blood-forming stem cells; they were not purified. Insulin regulates glucose use. Changing a downstream regulatory programme or a selected small RNA supported parts of the metabolic pathway. The study did not establish a physical receptor: JARID2 complex or identify one DNA mark as the cause. Its observational human samples and experiments on mouse fat cells did not establish prevention of diabetes in children. [5]
Another study combined a laboratory-made receptor activator with a substance inhibiting a protein called BRD9. The combination changed gene-regulating protein groups and improved selected mouse glucose, insulin and pancreatic-cell measures. Results depended on the model and combination; single treatments were sometimes ineffective. Other tissues or drug effects could contribute, and one protein contact was not isolated as the sole cause. Human cells studied outside the body were not a treatment trial. No lasting effect after stopping treatment or ordinary vitamin D3 benefit was established. [6]
Kidney, liver and blood-vessel outcomes
A kidney study combined direct binding between isolated protein parts with tests of reduced gene activation and mouse injury. Experimental ligands reduced scarring, and a longer experiment improved a kidney-function marker. This remained a gene-regulation mechanism, even though it differed from the usual receptor activation route. Calcium changes and animal-model limits prevent claims of completely calcium-neutral safety or established human kidney treatment. [7]
The liver study found a different pattern of receptor and regulatory-protein behaviour at DNA, linked with less scarring in a mouse injury model. It did not demonstrate the same isolated-protein binding mechanism as the kidney study, prove every assigned gene caused the outcome, or measure improved clinical liver function. It shared investigators with the pancreatic study, so the two were not independent teams confirming one identical mechanism. [8]
A blood-vessel study deliberately used toxic injected vitamin D3 in mice and produced harmful mineral deposits. Changing the RUNX2 regulator protected against deposits even when blood calcium remained high. Removing the vitamin D receptor also altered calcium, complicating the interpretation. The experiments did not isolate one protein contact or establish cardiovascular benefit. They do not predict harm from ordinary oral intake. [9]
Local structure has its own limits
Rat-cell and brain-slice experiments linked receptor function with myelin-associated structure. Myelin insulates nerve fibres. Added active hormone initially gave no extra cell-maturation response under ordinary serum conditions; a response appeared after different culture conditions. The work did not isolate one receptor-partner contact or measure nerve conduction, behaviour or human repair. Local structure was not a whole-animal neurological benefit. [10]
Mouse muscle experiments linked receptor signalling in immature cells with less fat-cell formation. Deficiency-related fat accumulation differed between old and young mice. A regulatory protein changed without its RNA changing, so transcriptional suppression of that gene was not demonstrated. Neither a rescue test of that regulator nor a physical receptor complex established the proposed mechanism. Muscle force was not measured, and the human muscle observations lacked vitamin D blood measurements. Tissue composition cannot be called improved strength. [11]
A receptor unable to bind hormone normally still restored selected hair-cycle outcomes in genetically altered mice. That does not make every skin function independent of hormone binding, or show that one partner interaction caused the rescue. Engineered expression and the whole-body receptor-deficient background limit interpretation. Receptor loss is different from low vitamin D supply. [12]
What did the human trial add?
A year-long randomized trial in older adults compared oral vitamin D3 with an inactive treatment. Blood vitamin D rose, but the primary controlled analysis found no clear whole-blood gene response or convincing change in selected inflammatory signals. One late sample of mixed blood cells cannot exclude earlier, smaller or other-tissue effects. It also cannot establish that every animal-study physiological outcome is absent in people. [13]
The studies connect particular regulatory changes with particular outcomes; they do not support one uniformly beneficial response. Molecular findings, local structure, whole-body physiology and human treatment benefit require different evidence. These findings provide no personal treatment dose.
Scientific sources
[1] Intestinal vitamin D receptor is required for normal calcium and bone metabolism in mice. Xue Y, Fleet JC. Gastroenterology. 2009;136(4):1317-27, e1-2. DOI 10.1053/j.gastro.2008.12.051; PMID 19254681; PMCID PMC2695717.
[2] In Vivo Contribution of Cyp24a1 Promoter Vitamin D Response Elements. Meyer MB, Lee SM, Towne JM, Cichanski SR, Kaufmann M, Jones G, Pike JW. Endocrinology. 2024;165(11):bqae134. DOI 10.1210/endocr/bqae134; PMID 39363152; PMCID PMC11487884.
[3] Coactivator-independent vitamin D receptor signaling causes severe rickets in mice, that is not prevented by a diet high in calcium, phosphate, and lactose. Doms S, Verlinden L, Janssens I, Vanhevel J, Eerlings R, Houtman R, Kato S, Mathieu C, Decallonne B, Carmeliet G, Verstuyf A. Bone research. 2024;12(1):44. DOI 10.1038/s41413-024-00343-7; PMID 39164247; PMCID PMC11335873.
[4] 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. The Journal of clinical investigation. 2002;110(2):229-38. DOI 10.1172/JCI15219; PMID 12122115; PMCID PMC151055.
[5] Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes. Oh J, Riek AE, Bauerle KT, Dusso A, McNerney KP, Barve RA, Darwech I, Sprague JE, Moynihan C, Zhang RM, Kutz G, Wang T, Xing X, Li D, Mrad M, Wigge NM, Castelblanco E, Collin A, Bambouskova M, Head RD, Sands MS, Bernal-Mizrachi C. Nature communications. 2023;14(1):3278. DOI 10.1038/s41467-023-38849-z; PMID 37311757; PMCID PMC10264405.
[6] Vitamin D Switches BAF Complexes to Protect β Cells. Wei Z, Yoshihara E, He N, Hah N, Fan W, Pinto AFM, Huddy T, Wang Y, Ross B, Estepa G, Dai Y, Ding N, Sherman MH, Fang S, Zhao X, Liddle C, Atkins AR, Yu RT, Downes M, Evans RM. Cell. 2018;173(5):1135-1149.e15. DOI 10.1016/j.cell.2018.04.013; PMID 29754817; PMCID PMC5987229.
[7] A nonclassical vitamin D receptor pathway suppresses renal fibrosis. Ito I, Waku T, Aoki M, Abe R, Nagai Y, Watanabe T, Nakajima Y, Ohkido I, Yokoyama K, Miyachi H, Shimizu T, Murayama A, Kishimoto H, Nagasawa K, Yanagisawa J. The Journal of clinical investigation. 2013;123(11):4579-4594. DOI 10.1172/jci67804; PMID 24135137; PMCID PMC3809783.
[8] A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, Leblanc M, Coulter S, He M, Scott C, Lau SL, Atkins AR, Barish GD, Gunton JE, Liddle C, Downes M, Evans RM. Cell. 2013;153(3):601-613. DOI 10.1016/j.cell.2013.03.028; PMID 23622244; PMCID PMC3673534.
[9] Functional cooperation between vitamin D receptor and Runx2 in vitamin D-induced vascular calcification. Han MS, Che X, Cho GH, Park HR, Lim KE, Park NR, Jin JS, Jung YK, Jeong JH, Lee IK, Kato S, Choi JY. PloS one. 2013;8(12):e83584. DOI 10.1371/journal.pone.0083584; PMID 24349534; PMCID PMC3861528.
[10] Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation. de la Fuente AG, Errea O, van Wijngaarden P, Gonzalez GA, Kerninon C, Jarjour AA, Lewis HJ, Jones CA, Nait-Oumesmar B, Zhao C, Huang JK, ffrench-Constant C, Franklin RJ. The Journal of cell biology. 2015;211(5):975-985. DOI 10.1083/jcb.201505119; PMID 26644513; PMCID PMC4674280.
[11] Lack of vitamin D signalling in mesenchymal progenitors causes fatty infiltration in muscle. Hosoyama T, Kawai-Takaishi M, Iida H, Yamamoto Y, Nakamichi Y, Watanabe T, Takemura M, Kato S, Uezumi A, Matsui Y. Journal of cachexia, sarcopenia and muscle. 2024;15(3):907-918. DOI 10.1002/jcsm.13448; PMID 38533539; PMCID PMC11154772.
[12] Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis. Skorija K, Cox M, Sisk JM, Dowd DR, MacDonald PN, Thompson CC, Demay MB. Molecular endocrinology (Baltimore, Md.). 2005;19(4):855-862. DOI 10.1210/me.2004-0415; PMID 15591533.
[13] Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial. Berlanga-Taylor AJ, Plant K, Dahl A, Lau E, Hill M, Sims D, Heger A, Emberson J, Armitage J, Clarke R, Knight JC. EBioMedicine. 2018;31:133-142. DOI 10.1016/j.ebiom.2018.04.010; PMID 29685792; PMCID PMC6013786.
Related reading
Coactivator-independent vitamin D receptor signaling causes severe rickets in mice, that is not prevented by a diet high in calcium, phosphate, and lactose
The vitamin D receptor (VDR) plays a critical role in the regulation of mineral and bone homeostasis.
Original paper ↗Read more →Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes
Environmental factors may alter the fetal genome to cause metabolic diseases.
Original paper ↗Read more →Functional Cooperation between Vitamin D Receptor and Runx2 in Vitamin D-Induced Vascular Calcification
The transdifferentiation of vascular smooth muscle cells (VSMCs) into osteoblast-like cells has been implicated in the context of vascular calcification.
Original paper ↗Read more →Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial
Elucidating the mechanisms of action of drug treatments in humans is challenging, but application of functional genomic approaches in randomized trials may afford an opportunity to systematically assess molecular responses.
Original paper ↗Read more →In Vivo Contribution of Cyp24a1 Promoter Vitamin D Response Elements
CYP24A1 is a multifunctional, P450 mitochondrial enzyme that catabolizes the vitamin D hormone (calcitriol, 1,25(OH)2D3), its precursor (calcifediol, 25(OH)D3), and numerous vitamin D metabolites.
Original paper ↗Read more →Lack of vitamin D signalling in mesenchymal progenitors causes fatty infiltration in muscle
In this study, we aimed to clarify the role of vitamin D signalling in MP kinetics, with a focus on adipogenesis.
Original paper ↗Read more →Evolution of Vitamin D Status and Vitamin D Receptor Gene Expression Among Professional Handball Athletes During a Competitive Period. Relationship with Body Composition, Calcium, Magnesium and Phosphorous
Introduction: A generalized risk of vitamin D deficiency exists worldwide affecting also professional and elite athletes.
Original paper ↗Read more →Diverse Regulation of Vitamin D Receptor Gene Expression by 1,25-Dihydroxyvitamin D and ATRA in Murine and Human Blood Cells at Early Stages of Their Differentiation
Vitamin D receptor (VDR) is present in multiple blood cells, and the hormonal form of vitamin D, 1,25-dihydroxyvitamin D (1,25D) is essential for the proper functioning of the immune system.
Original paper ↗Read more →Investigating the level of vitamin D receptor gene expression in two tumoral and healthy breast tissues in breast cancer patients and its association with prognostic factors
This study aimed to investigate the level of vitamin D receptor gene expression in two tumoral and healthy breast tissues in breast cancer patients and its association with prognostic factors.
Original paper ↗Read more →Investigating the level of vitamin D receptor gene expression in two tumoral and healthy breast tissues in breast cancer patients and its association with prognostic factors
This study aimed to investigate the level of vitamin D receptor gene expression in two tumoral and healthy breast tissues in breast cancer patients and its association with prognostic factors.
Original paper ↗Read more →Osteoblast-Specific Transcription Factor Osterix Increases Vitamin D Receptor Gene Expression in Osteoblasts
For example, calvaria obtained from Osx-null embryos displayed dramatic reductions in VDR expression compared to wild-type calvaria.
Original paper ↗Read more →Plasma 25-Hydroxyvitamin D Levels and VDR Gene Expression in Peripheral Blood Mononuclear Cells of Leukemia Patients and Healthy Subjects in Central Kazakhstan
A similar difference was observed in both younger (60 years old) participants, though there was no association between 25(OH)D concentration and age within the patient group.
Original paper ↗Read more →Regulation of tight junction gene expression in the kidney of calbindin-D9k and/or: D28k knockout mice after consumption of a calcium: or a calcium/vitamin D-deficient diet
Transcripts and proteins of tight junction related genes (occludin, ZO-1, and claudins) were examined in CaBP-9 k-and/or-28 k-deficient mice as well as the effect of dietary calcium and/or vitamin D supplementation.
Original paper ↗Read more →The association between body mass index elevation and differentiation in vitamin D receptor gene expression, genetic polymorphism, and oxidative stress in adult Egyptian individuals
Vitamin D plays a central role in maintaining calcium, phosphorus, and bone homeostasis in close interaction with the parathyroid hormone.
Original paper ↗Read more →The impact of vitamin D supplementation on VDR gene expression and body composition in monozygotic twins: randomized controlled trial
The objective of this randomised controlled study is to examine the effect of vitamin D supplementation on body composition and the expression of the vitamin D receptor (VDR) mRNA.
Original paper ↗Read more →Tissue-Specific VDR Pathway Gene Expression Is Not Associated with Circulating 25OHD in Adolescents with Severe Obesity
This study examined the expression patterns of VDR-target genes across metabolically diverse tissues and compared these molecular measures with circulating serum 25-hydroxyvitamin D (25OHD), the current clinical marker of vitamin D status.
Original paper ↗Read more →VDR, SOD-2, and CYP24A1 Gene Expression in Different Genotypes of BsmI SNP of the Vitamin D Receptor Gene in Individuals with Hypovitaminosis
Objective: To evaluate the effect of the genotypes of BsmI single nucleotide polymorphism (SNP) of the VDR gene on VDR, SOD2, and CYP24A1 gene expression in individuals with low serum vitamin D levels.
Original paper ↗Read more →Vitamin D Receptor Gene Expression and Function in a South African Population: Ethnicity, Vitamin D and FokI
Polymorphisms of the vitamin D receptor gene (VDR) have been associated inconsistently with various diseases, across populations of diverse origin.
Original paper ↗Read more →Vitamin D Receptor Gene Expression in Adipose Tissue of Obese Individuals is Regulated by miRNA and Correlates with the Pro-Inflammatory Cytokine Level
Results: VDR mRNA levels were higher, while CYP27B1 levels were lower in adipose tissues of obese patients than in those of normal-weight controls (VAT: P = 0.04, SAT: P < 0.0001 and VAT: P = 0.004, SAT: P = 0.016, respectively).
Original paper ↗Read more →Vitamin D Receptor Polymorphisms and Their Association with Nrf2-Dependent Gene Expression in Oxidative Stress Resilience in Cognitively Healthy Aging
For TaqI, homozygous carriers of the protective C allele exhibited greater PBMC viability (p < 0.0465) and higher Nrf2 (p = 0.0324), HMOX1 (p = 0.0206), and GST (p = 0.0029) expression compared with carriers of the risk T allele (TC or TT).
Original paper ↗Read more →Vitamin D and Gene Expression
How vitamin D influences gene expression through vitamin D receptors, DNA response elements, transcription control, and changes in cellular behaviour.
Read more →Original sources
Intestinal vitamin D receptor is required for normal calcium and bone metabolism in mice.
Published in Xue Y, Fleet JC. Gastroenterology (2009).
Publication details
[1] Intestinal vitamin D receptor is required for normal calcium and bone metabolism in mice. Xue Y, Fleet JC. Gastroenterology. 2009;136(4):1317-27, e1-2. DOI 10.1053/j.gastro.2008.12.051; PMID 19254681; PMCID PMC2695717.
In Vivo Contribution of Cyp24a1 Promoter Vitamin D Response Elements.
Published in Meyer MB, Lee SM, Towne JM, Cichanski SR, Kaufmann M, Jones G, Pike JW. Endocrinology (2024).
Publication details
[2] In Vivo Contribution of Cyp24a1 Promoter Vitamin D Response Elements. Meyer MB, Lee SM, Towne JM, Cichanski SR, Kaufmann M, Jones G, Pike JW. Endocrinology. 2024;165(11):bqae134. DOI 10.1210/endocr/bqae134; PMID 39363152; PMCID PMC11487884.
Coactivator-independent vitamin D receptor signaling causes severe rickets in mice, that is not prevented by a diet high in calcium, phosphate, and lactose.
[3] Coactivator-independent vitamin D receptor signaling causes severe rickets in mice, that is not prevented by a diet high in calcium, phosphate, and lactose.
Publication details
[3] Coactivator-independent vitamin D receptor signaling causes severe rickets in mice, that is not prevented by a diet high in calcium, phosphate, and lactose. Doms S, Verlinden L, Janssens I, Vanhevel J, Eerlings R, Houtman R, Kato S, Mathieu C, Decallonne B, Carmeliet G, Verstuyf A. Bone research. 2024;12(1):44. DOI 10.1038/s41413-024-00343-7; PMID 39164247; PMCID PMC11335873.
1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system.
Published in Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. The Journal of clinical investigation (2002).
Publication details
[4] 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. The Journal of clinical investigation. 2002;110(2):229-38. DOI 10.1172/JCI15219; PMID 12122115; PMCID PMC151055.
Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes
Environmental factors may alter the fetal genome to cause metabolic diseases.
Publication details
[5] Embryonic vitamin D deficiency programs hematopoietic stem cells to induce type 2 diabetes. Oh J, Riek AE, Bauerle KT, Dusso A, McNerney KP, Barve RA, Darwech I, Sprague JE, Moynihan C, Zhang RM, Kutz G, Wang T, Xing X, Li D, Mrad M, Wigge NM, Castelblanco E, Collin A, Bambouskova M, Head RD, Sands MS, Bernal-Mizrachi C. Nature communications. 2023;14(1):3278. DOI 10.1038/s41467-023-38849-z; PMID 37311757; PMCID PMC10264405.
Vitamin D Switches BAF Complexes to Protect β Cells.
[6] Vitamin D Switches BAF Complexes to Protect β Cells.
Publication details
[6] Vitamin D Switches BAF Complexes to Protect β Cells. Wei Z, Yoshihara E, He N, Hah N, Fan W, Pinto AFM, Huddy T, Wang Y, Ross B, Estepa G, Dai Y, Ding N, Sherman MH, Fang S, Zhao X, Liddle C, Atkins AR, Yu RT, Downes M, Evans RM. Cell. 2018;173(5):1135-1149.e15. DOI 10.1016/j.cell.2018.04.013; PMID 29754817; PMCID PMC5987229.
A nonclassical vitamin D receptor pathway suppresses renal fibrosis.
[7] A nonclassical vitamin D receptor pathway suppresses renal fibrosis.
Publication details
[7] A nonclassical vitamin D receptor pathway suppresses renal fibrosis. Ito I, Waku T, Aoki M, Abe R, Nagai Y, Watanabe T, Nakajima Y, Ohkido I, Yokoyama K, Miyachi H, Shimizu T, Murayama A, Kishimoto H, Nagasawa K, Yanagisawa J. The Journal of clinical investigation. 2013;123(11):4579-4594. DOI 10.1172/jci67804; PMID 24135137; PMCID PMC3809783.
A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response.
[8] A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response.
Publication details
[8] A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, Leblanc M, Coulter S, He M, Scott C, Lau SL, Atkins AR, Barish GD, Gunton JE, Liddle C, Downes M, Evans RM. Cell. 2013;153(3):601-613. DOI 10.1016/j.cell.2013.03.028; PMID 23622244; PMCID PMC3673534.
Functional Cooperation between Vitamin D Receptor and Runx2 in Vitamin D-Induced Vascular Calcification
The transdifferentiation of vascular smooth muscle cells (VSMCs) into osteoblast-like cells has been implicated in the context of vascular calcification.
Publication details
[9] Functional cooperation between vitamin D receptor and Runx2 in vitamin D-induced vascular calcification. Han MS, Che X, Cho GH, Park HR, Lim KE, Park NR, Jin JS, Jung YK, Jeong JH, Lee IK, Kato S, Choi JY. PloS one. 2013;8(12):e83584. DOI 10.1371/journal.pone.0083584; PMID 24349534; PMCID PMC3861528.
Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation.
[10] Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation.
Publication details
[10] Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation. de la Fuente AG, Errea O, van Wijngaarden P, Gonzalez GA, Kerninon C, Jarjour AA, Lewis HJ, Jones CA, Nait-Oumesmar B, Zhao C, Huang JK, ffrench-Constant C, Franklin RJ. The Journal of cell biology. 2015;211(5):975-985. DOI 10.1083/jcb.201505119; PMID 26644513; PMCID PMC4674280.
Lack of vitamin D signalling in mesenchymal progenitors causes fatty infiltration in muscle.
[11] Lack of vitamin D signalling in mesenchymal progenitors causes fatty infiltration in muscle.
Publication details
[11] Lack of vitamin D signalling in mesenchymal progenitors causes fatty infiltration in muscle. Hosoyama T, Kawai-Takaishi M, Iida H, Yamamoto Y, Nakamichi Y, Watanabe T, Takemura M, Kato S, Uezumi A, Matsui Y. Journal of cachexia, sarcopenia and muscle. 2024;15(3):907-918. DOI 10.1002/jcsm.13448; PMID 38533539; PMCID PMC11154772.
Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis.
Published in Skorija K, Cox M, Sisk JM, Dowd DR, MacDonald PN, Thompson CC, Demay MB. Molecular endocrinology (Baltimore, Md.) (2005).
Publication details
[12] Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis. Skorija K, Cox M, Sisk JM, Dowd DR, MacDonald PN, Thompson CC, Demay MB. Molecular endocrinology (Baltimore, Md.). 2005;19(4):855-862. DOI 10.1210/me.2004-0415; PMID 15591533.
Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial.
[13] Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial.
Publication details
[13] Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial. Berlanga-Taylor AJ, Plant K, Dahl A, Lau E, Hill M, Sims D, Heger A, Emberson J, Armitage J, Clarke R, Knight JC. EBioMedicine. 2018;31:133-142. DOI 10.1016/j.ebiom.2018.04.010; PMID 29685792; PMCID PMC6013786.